SCHEMBL6530210

SCHEMBL6530210

COc1ccc(Sc2nc(Nc3cccc(F)c3)nc(N[C@@H](CC(C)C)C(=O)NCCCN3CCCC3=O)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.45
RAB9A P51151 1/20 0.45
ATM Q13315 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
RCE1 Q9Y256 1/20 0.42
ALDH1A1 P00352 3/20 0.42
CTSK P43235 2/20 0.42
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TYRO3 Q06418 3/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
EGFR P00533 1/20 0.36
ITK Q08881 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6528788 0.89 CTSK (0.43) CTSK
SCHEMBL6531499 0.85 PDPK1 (0.45) RAB9ARCE1ALDH1A1CTSKKDM4E
SCHEMBL6530478 0.84 CTSK (0.43) CTSK
SCHEMBL6530634 0.83 CTSK (0.45) SMN1; SMN2ALDH1A1CTSKHPGD
SCHEMBL6528746 0.82 CTSK (0.44) CTSKKMT2A
SCHEMBL6532662 0.81 CTSK (0.42) ATMALDH1A1CTSKHPGDL3MBTL1
SCHEMBL6528931 0.81 KCNH3 (0.41) SMN1; SMN2ALDH1A1CTSKL3MBTL1KMT2A
SCHEMBL6508192 0.81 KCNH3 (0.41) ALDH1A1CTSKMAPK1L3MBTL1KMT2A
SCHEMBL6508189 0.81 KCNH3 (0.41) ALDH1A1CTSKMAPK1L3MBTL1KMT2A
SCHEMBL6528847 0.81 SYK (0.43) ALDH1A1CTSKL3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005082884-A2 2-PYRIDIN-2YL-PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF GASTRO-ESOPHAGEA L REFLUX DISEASE ASTRAZENECA AB (SE) 2005-09-09 WO disclosed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed